Christopher L. Lotz Qualigen Therapeutics, Inc. (QLGN) insider trading activity

QLGN Quotes by TradingView

Christopher L. Lotz is Vice President of Finance, CFO of Qualigen Therapeutics, Inc.. Currently has a direct ownership of 12,541 shares of QLGN, which is worth approximately $2,131. The most recent transaction as insider was on Apr 16, 2021, when has been sold 2,700 shares (Common Stock) at a price of $1.86 per share, resulting in proceeds of $5,022. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K
0% 3M change
0% 12M change
Total Value Held $2,131

Christopher L. Lotz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2021
BUY
Open market or private purchase
$5,022 $1.86 p/Share
2,700 Added 17.72%
12,541 Common Stock
CLL

Christopher L. Lotz

Vice President of Finance, CFO
Carlsbad, CA

Track Institutional and Insider Activities on QLGN

Follow Qualigen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QLGN shares.

Notify only if

Insider Trading

Get notified when an Qualigen Therapeutics, Inc. insider buys or sells QLGN shares.

Notify only if

News

Receive news related to Qualigen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on QLGN